Global Journal of Commerce & Management Perspective
Open Access

Abstract

Do Chinese Pharmaceutical Companies Compete With Intellectual Capital?-- Evidence from 2001 to 2013

Shenglei Pi.

Is Chinese pharmaceutical company behavior like a high-tech companies in market competition? This paper empirically tested data of Chinese pharmaceutical firms from 2001 to 2013, and found out that: dislike high-tech companies, Chinese pharmaceutical firms have more perception to adopt normal but frequent competitive actions rather than highly innovative moves, and they prefers to start attack or respond basing on tangible resources similarity rather than intellectual capital. The test found out only medium Chinese pharmaceutical firms perhaps have more interests on innovation and adopt deviance moves.